Clinical Performance Characteristics of the Swift Normalase Amplicon Panel for Sensitive Recovery of Severe Acute Respiratory Syndrome Coronavirus 2 Genomes-Reference-Cited by-同舟云学术

Clinical Performance Characteristics of the Swift Normalase Amplicon Panel for Sensitive Recovery of Severe Acute Respiratory Syndrome Coronavirus 2 Genomes

Published:2022-09 Issue:9 Volume:24 Page:963-976
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Shrestha Lasata^ORCID,Lin Michelle J.^ORCID,Xie Hong,Mills Margaret G.^ORCID,Mohamed Bakhash Shah A.^ORCID,Gaur Vinod P.,Livingston Robert J.^ORCID,Castor Jared,Bruce Emily A.^ORCID,Botten Jason W.,Huang Meei-Li^ORCID,Jerome Keith R.,Greninger Alexander L.^ORCID,Roychoudhury Pavitra^ORCID

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference53 articles.

1. Data, disease and diplomacy: GISAID’s innovative contribution to global health;Elbe;Glob Chall,2017

2. Jumping a moving train: SARS-CoV-2 evolution in real time;Moustafa;J Pediatr Infect Dis Soc,2021

3. Rapid, sensitive, full-genome sequencing of severe acute respiratory syndrome coronavirus 2;Paden;Emerg Infect Dis,2020

4. Coast-to-coast spread of SARS-CoV-2 during the early epidemic in the United States;Fauver;Cell,2020

5. Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California;Deng;Science,2020

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Positive selection underlies repeated knockout of ORF8 in SARS-CoV-2 evolution;Nature Communications;2024-04-13

2. Outcomes in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy Recipients With Pre–Cellular Therapy SARS-CoV-2 Infection;Clinical Infectious Diseases;2024-03-01

3. Clinical outcomes and frequency of persistent infection among immunosuppressed patients treated with bebtelovimab for COVID‐19 infection at an ambulatory cancer center;Transplant Infectious Disease;2024-01-08

4. Integration of SARS-CoV-2 testing and genomic sequencing into influenza sentinel surveillance in Uganda, January to December 2022;Microbiology Spectrum;2023-12-12

5. Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial;The Lancet Respiratory Medicine;2023-11